Position in MEDP
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$27,009
+$2,520 QoQ
Shares Held
51
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#583
of 678 holders
Holding Since
Jun 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Johnson Financial Group, Inc. holds $1,960,047 across 8 Diagnostics & Research names. MEDP ranks #5 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
1,437 | $756,494 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,487 | $745,522 | |
| 3 | DHR |
Danaher Corp /De/
|
1,742 | $331,816 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
304 | $58,738 | |
| 5 | MEDP |
Medpace Holdings, Inc.
This page
|
51 | $27,009 | |
| 6 | DGX |
Quest Diagnostics Inc
|
89 | $18,863 | |
| 7 | NTRA |
Natera, Inc.
|
61 | $16,558 | |
| 8 | A |
Agilent Technologies, Inc.
|
38 | $5,047 |
All Filings in MEDP
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,009 | 51 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $24,489 | 51 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $28,644 | 51 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $56,557 | 110 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $16,006 | 51 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $16,453 | 54 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,600 | 59 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,008 | 18 | Shares | Defined | 2024-11-13 | |
| 2021-12-31 | $870 | 4 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,514 | 8 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,413 | 8 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||